TX-AUREA-SOFTWARE-INC
11.1.2022 17:02:08 CET | Business Wire | Press release
Aurea Software Inc. , the “Netflix of business software,” announced Deutsche Telekom is piloting its first-ever Virtual Office using Sococo software from Aurea . Used to better connect its distributed workforce and increase culture and collaboration across the company’s customer service teams, the pilot will run until March.
Deutsche Telekom customer service teams — comprised of 30,000 employees across Germany — are distributed throughout the country. Despite using a geographically distributed and hybrid work setting, team members need to be able to “work as one” to deliver optimal customer experiences.
Using Aurea’s Sococo solution, Deutsche Telekom is at the forefront of solving this problem of connection and culture in the geographically distributed and hybrid workplace by launching a Virtual Office that allows workers to enjoy the same level of connection and presence online that they once enjoyed in person.
“Hybrid work is here to stay. The pandemic started it, but workers embraced it, and there is no going back to a 100 percent in-person work world. And while research supports that working from home has many benefits, it also creates unique challenges,” said Scott Brighton, CEO of Aurea. “Workers can’t connect in the hallways the way they once did. They don’t meet new people on campus or when visiting other offices around the world. Common virtual meeting communication tools have made their work world smaller — encouraging them to stay in regular communication with people they already know, but not empowering them to discover new people or new ideas. This has led to a lack of experiencing a vibrant culture of diversity that was more prominent when workers came into a physical office.”
Brighton added, “With the creation of its Virtual Office, Deutsche Telekom is leading the industry by creating a hybrid-work environment that offers employees more ways to connect, collaborate, and build culture no matter where they are in the world.”
Deutsche Telekom’s Virtual Office looks and feels like an actual office — however, it’s online instead of in a physical building. There are gathering spaces, meeting and conference rooms, and even break areas, giving every employee the ability to see where colleagues are and what they are doing. This creates a rich sense of presence that is missing from basic communication tools that only show a generic status color next to a list of colleagues. Employees can meet and connect with new people using virtual meeting experiences specifically designed to create the casual connections present in in-office settings. For example, Deutsche Telekom’s Virtual Office has a Coffee Roulette room where employees are randomly connected to another co-worker they may not already know. They can spend a few minutes getting to know each other — sharing details about their roles, how they can help each other, and even what inspires them.
Aurea’s Sococo solution is centered around going beyond the basic communication aspects that traditional virtual meeting platforms provide to build true culture and connection.
“Like many large enterprises, Deutsche Telekom thrives, in part, due to the diverse backgrounds and skills of our workforce coming together to share knowledge and collaborate to solve customer issues more efficiently,” said Gereon Hammel, vice president of business development at Deutsche Telekom. “Many of the methods we’ve traditionally relied on to forge this collaboration are lost when functions are shrunk to closed and niche calls with immediate team members. By partnering with Aurea to launch this Virtual Office, we can enable important components of an in-person work environment within our hybrid work setting. This allows us to leverage our scale and diverse workforce, without requiring everyone to be in the same physical office space. The ease at which we can implement the Sococo solution across our team means our Virtual Office can be implemented in a matter of minutes.”
REGISTER TODAY : Hear more from Gereon Hammel and Scott Brighton on how to enable digital connection and build a Virtual Office during VentureBeat’s Future of Work Summit . Sign up today for the January 12 event.
About Aurea:
Aurea helps global businesses accelerate digital transformation through unlimited access to the world’s first business software library, which includes solutions that enable the Future of Commerce, work, and IT. Our customers enjoy access to every product in our portfolio, all of which are cloud-based, enterprise-scale, and easy-to-use with one simple subscription. Our unique operating model and acquisition strategy grows our software portfolio every year, creating unparalleled value and unlimited possibility. For more information, visit Aurea.com .
View source version on businesswire.com: https://www.businesswire.com/news/home/20220111005342/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
From Network Automation to Agentic NetOps: NetBrain Sets the Standard for Deploying AI in Network Operations29.5.2026 15:00:00 CEST | Press release
Newest expansion of the NetBrain platform delivers Agent Skills, AI Path Doctor, MCP Server, and expanded cross-domain integrations, extending the agentic capabilities already running in production at hundreds of enterprises. NetBrain Technologies, Inc. today announced major new platform features that advance Agentic NetOps from an emerging category to operational reality. NetBrain's clients are already deploying agents that are diagnosing and remediating issues across complex multi-vendor enterprise networks. These new features further extend the platform with new agent tooling, cross-domain context, and open interfaces for the broader agentic enterprise. Early customer outcomes show the magnitude of the shift: A leading health insurer used NetBrain's Deep Diagnosis agent to diagnose and resolve a weeks old VPN connectivity issue in under five minutes. A large manufacturer resolved a critical device issue with a single prompt, isolating the root cause across the network path in under
Adtran resolves long-running patent litigation, reinforcing commitment to defend innovation29.5.2026 14:00:00 CEST | Press release
News summary: Non-practicing entity litigation continues to create costly, time-consuming pressure across the technology industry Adtran has reached a full settlement following counterclaims, with payment made to Adtran and all claims dismissed with prejudice Outcome reflects Adtran’s commitment to defend its innovations, customers and business against meritless patent assertions Adtran today announced it has resolved a patent litigation matter, resulting in a full settlement and dismissal of all claims with prejudice. The case, initiated in 2020 by a non-practicing entity asserting five patents, was transferred to the US District Court for the Northern District of Alabama in 2021 following a successful motion by Adtran. Adtran subsequently filed counterclaims, including bad-faith patent assertion under Alabama statutory law. The settlement includes payment to Adtran to resolve its counterclaims. Terms of the agreement remain confidential. “This outcome reflects a disciplined and consi
Meiji Seika Pharma Invests in GHIC’s Global Health Security Fund29.5.2026 13:00:00 CEST | Press release
Meiji Seika Pharma Co., Ltd. (Headquarters: Tokyo, Japan; President and Representative Director: Toshiaki Nagasato) today announced that it has committed to invest in the Global Health Security Fund (GHSF), which is sponsored by Global Health Investment Corporation (GHIC), a New York-based nonprofit organization. Through this investment, Meiji Seika Pharma will support the acceleration of innovations addressing critical global health challenges, including pandemic preparedness and antimicrobial resistance (AMR). GHIC is a mission‑driven nonprofit organization that deploys private investment strategies to generate both global health impact and financial returns. GHIC recently closed its second fund in GHSF. With more than a decade of experience investing in the field of infectious disease, GHIC has contributed to addressing major global health challenges. Its portfolio companies have successfully commercialized more than a dozen products, collectively reaching over 600 million people wo
IFF Enters Into Agreement to Sell Its Food Ingredients Business to CVC29.5.2026 12:50:00 CEST | Press release
Transaction advances portfolio transformation, sharpens focus on higher-growth, higher-margin businesses, strengthens balance sheet, and enhances value creation for shareholders IFF (NYSE: IFF), a global leader in flavors, fragrances, food ingredients, and health and biosciences, today announced that it has entered into an agreement to sell its Food Ingredients business to funds advised by CVC Capital Partners, a leading global private markets manager, in a transaction that values the business at approximately $4.3 billion, representing an enterprise value-to-EBITDA multiple of approximately 10x. As part of the transaction, IFF has chosen to retain an approximately 10% minority equity interest in the business, or approximately $200 million, permitting continued collaboration and cooperation between IFF and Food Ingredients and allowing IFF and its shareholders to participate in future value creation under its new ownership. The transaction marks a significant step in IFF’s portfolio tr
BeOne Medicines Establishes Standard for Long-Term Disease Control in CLL with BRUKINSA 78-Month Data at ASCO 202629.5.2026 12:00:00 CEST | Press release
Data represents the longest reported follow-up for a next-generation BTK inhibitor in CLL, showing sustained disease control and benefit that extends beyond first-line therapyBRUKINSA plus next-generation BCL2 inhibitor sonrotoclax (ZS) delivered deep, durable, and rapid uMRD responses, raising the bar for potential time-limited treatments in CLLData reinforce BeOne’s leadership in CLL and the strength of its foundational hematology franchise BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, is advancing the treatment paradigm in chronic lymphocytic leukemia (CLL) at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting. With extensive long-term follow-up, the SEQUOIA study of BRUKINSA® (zanubrutinib) reinforces its role as the foundational BTK inhibitor, showing sustained disease control over years of therapy. These findings are further supported by real-world evidence across three large analyses encompassing more than 250,000 pati
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
